294
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

, PhD, , MD PhD FRCPC & , PhD
Pages 219-226 | Published online: 06 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Salvatore D’Angelo, Giuseppina Tramontano, Michele Gilio, Pietro Leccese & Ignazio Olivieri. (2017) Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders. Open Access Rheumatology: Research and Reviews 9, pages 21-28.
Read now
Monica Montepaone, Ennio Lubrano, Alessia Carboni & Antonio Spadaro. (2014) Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis. Open Access Rheumatology: Research and Reviews 6, pages 7-13.
Read now

Articles from other publishers (2)

Salvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, Luca Cantarini, Antonio Carletto, Maria Sole Chimenti, Andrea Delle Sedie, Rosario Foti, Roberto Gerli, Claudia Lomater, Ennio Lubrano, Antonio Marchesoni, Alen Zabotti, Carlo Salvarani, Rossana Scrivo, Raffaele Scarpa, Giuseppina Tramontano, Carlotta Nannini, Mariagrazia Lorenzin, Marta Fabbroni, Federica Martinis, Roberto Perricone, Linda Carli, Elisa Visalli, Guido Rovera, Fabio Massimo Perrotta, Luca Quartuccio, Alessio Altobelli, Luisa Costa, Laura Niccoli, Augusta Ortolan & Francesco Caso. (2019) Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study. Frontiers in Pharmacology 10.
Crossref
Raquel Cuchacovich, Rodolfo Perez-Alamino, Ignacio Garcia-Valladares & Luis R. Espinoza. (2012) Steps in the management of psoriatic arthritis: a guide for clinicians. Therapeutic Advances in Chronic Disease 3:6, pages 259-269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.